Active substance
Results for the substance gestoden ethinylestradiol
20 results
About this active substance
The combination of gestodene and ethinylestradiol is used as a combined oral contraceptive to prevent pregnancy. It is one of the most commonly used methods of hormonal contraception, providing effective protection when taken correctly.
- Gestodene is a third-generation progestin that mimics the action of natural progesterone. It prevents ovulation, thickens cervical mucus (blocking sperm entry), and alters the uterine lining, making it less favorable for implantation of a fertilized egg.
- Ethinylestradiol is a synthetic estrogen that regulates the menstrual cycle and contributes to ovulation prevention by inhibiting the secretion of gonadotropins (FSH and LH).
This combination is taken in tablet form, usually in a 21-day cycle of daily administration, followed by a 7-day break (or placebo tablets), during which withdrawal bleeding occurs.
Common side effects include nausea, headaches, breast tenderness, mood changes, weight gain, or breakthrough bleeding. In rare cases, more serious reactions such as venous thromboembolism, high blood pressure, or allergic reactions may occur.
It is important for patients to strictly follow their doctor’s instructions and not miss doses. Combined oral contraceptives are not recommended for women with a history of thrombosis, cardiovascular diseases, severe migraines with aura, or smokers over the age of 35. If unusual symptoms occur (such as severe headaches, chest pain, or leg swelling), a doctor should be consulted immediately.
- Gestodene is a third-generation progestin that mimics the action of natural progesterone. It prevents ovulation, thickens cervical mucus (blocking sperm entry), and alters the uterine lining, making it less favorable for implantation of a fertilized egg.
- Ethinylestradiol is a synthetic estrogen that regulates the menstrual cycle and contributes to ovulation prevention by inhibiting the secretion of gonadotropins (FSH and LH).
This combination is taken in tablet form, usually in a 21-day cycle of daily administration, followed by a 7-day break (or placebo tablets), during which withdrawal bleeding occurs.
Common side effects include nausea, headaches, breast tenderness, mood changes, weight gain, or breakthrough bleeding. In rare cases, more serious reactions such as venous thromboembolism, high blood pressure, or allergic reactions may occur.
It is important for patients to strictly follow their doctor’s instructions and not miss doses. Combined oral contraceptives are not recommended for women with a history of thrombosis, cardiovascular diseases, severe migraines with aura, or smokers over the age of 35. If unusual symptoms occur (such as severe headaches, chest pain, or leg swelling), a doctor should be consulted immediately.
-
-
LOGEST 0.075mg/0.02mg sugar-coated tablets BAYER ORIGINAL MEDICINE
-
HARMONET 0.075mg/0.020mg sugar-coated tablets PFIZER ORIGINAL MEDICINE
-
KARISSA 75mcg/20mcg sugar-coated tablets GEDEON RICHTER
-
KARISSA 75mcg/20mcg sugar-coated tablets GEDEON RICHTER
-
ARTIZIA 0.075mg/0.020mg sugar-coated tablets ZENTIVA
-
STODETTE 0.075mg/0.02mg sugar-coated tablets PHARMASWISS
-
MINELLA 60mcg/15mcg film-coated tablets TEVA
-
LISVY 60mcg/13mcg/24h transdermal patch GEDEON RICHTER ORIGINAL MEDICINE
-
VONILLE 60mcg/15mcg 60mcg/15micorgrame film-coated tablets EXELTIS
-
GESTODEN/ETINILESTRADIOL SANDOZ 75mcg/20mcg tablets
-
GESTODEN/ETINILESTRADIOL SANDOZ 75mcg/30mcg tablets
-
GESTODEN/ETINILESTRADIOL SANDOZ 60mcg/15mcg film-coated tablets
-
APLEEK 60mcg/13mcg/24h transdermal patch GEDEON RICHTER ORIGINAL MEDICINE
-
MARYNARKA 0.075mg/0.020mg tablets LEON
-
JULIPERLA 0.075mg/0.020mg tablets ACTAVIS
-
SYLGESTREL 75mcg/30mcg sugar-coated tablets ACTAVIS
-
SYLGESTREL 75mcg/20mcg sugar-coated tablets ACTAVIS
-
VENDIOL 15mcg/60mcg film-coated tablets GEDEON RICHTER
-
ZULFIJA 75mcg/30mcg sugar-coated tablets GEDEON RICHTER